PERTH: Emyria Limited has signed an agreement with Zelira Therapeutics to collect data from patients treated with insomnia drug Zenivol through Emyria’s specialist clinical services. Zelira is Perth-based company specialising in the development of cannabinoid-based medicines for the treatment of a variety of medical conditions including insomnia, autism and chronic non-cancer pain. Under the partnership,…